BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5995246)

  • 1. [On the treatment of lymphogranuloma].
    Hammer B
    Wien Med Wochenschr; 1966 Jun; 116(25):562-5. PubMed ID: 5995246
    [No Abstract]   [Full Text] [Related]  

  • 2. [First clinical experiences with methylhydrazine in treatment of malignant lymphogranuloma].
    Fazio M; Cavallero P; Sartoris S; Vergnano F; Pegoraro L
    Minerva Med; 1965 Dec; 56(99):4338-43. PubMed ID: 5323491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of Hodgkin's disease. General principles, applications and preliminary results of methods used at a Research Institute for leukemia and blood diseases].
    Teillet F; Weisgerber C; Dana M; Desprez-Curely JP; Jacquillat C; Bousquet R; Tanzer J; Boiron M; Bernard J
    Bull Cancer; 1971; 58(2):203-20. PubMed ID: 5143131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Hodgkin's disease with Natulan].
    Anglesio E
    Minerva Med; 1965 Dec; 56(100):4402-6. PubMed ID: 5324896
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
    Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of a methyl hydrazine derivative in the treatment of Hodgkin's disease].
    Hollard D; Schaerrer R
    Lyon Med; 1966 Apr; 215(17):1167-74. PubMed ID: 5930371
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hodgkin's disease and hematosarcomas. Treatment trial by 2 methylhydrazines].
    Mathe G; Schneider M; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Concours Med; 1965 Jul; 87(27):4555-62. PubMed ID: 5841618
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of treatment of malignant granuloma with Natulan Roche].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kolakowska-Polubiec K; Polubiec A
    Wiad Lek; 1968 Aug; 21(16):1417-9. PubMed ID: 5699696
    [No Abstract]   [Full Text] [Related]  

  • 10. [The place of a methylhydrazine in the treatment of malignant granuloma after 2 years of clinical experience].
    Introzzi P; Marinone G
    Minerva Med; 1966 Mar; 57(25):1133-8. PubMed ID: 5932015
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy of Hodgkin's disease.
    McElwain TJ
    Br J Haematol; 1971 Sep; 21(3):362. PubMed ID: 5569541
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
    Wagner K; Haas H; Meyerhold A
    Wien Klin Wochenschr; 1965 Sep; 77(36):589-602. PubMed ID: 5323247
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical treatment of Dupuytren's disease with a cytostatic agent (methylhydrazine)].
    Aron E
    Presse Med (1893); 1968 Oct; 76(41):1956. PubMed ID: 5724620
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
    Nissen I; Poulsen EH
    Ugeskr Laeger; 1967 Nov; 129(44):1472-6. PubMed ID: 4875225
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
    Holsti LR; Hjelt AL
    Ann Med Intern Fenn; 1967; 56(3):119-24. PubMed ID: 5630600
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of treatment of Hodgkin's disease in children with cytostatic drugs].
    Sroczyńska M; Miller W; Górniak J; Maszewska-Kuźniarz K
    Pediatr Pol; 1971 Feb; 46(2):189-92. PubMed ID: 5553864
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trial of treatment of Hodgkin's disease and other lymphomas with a methylhydrazine, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride].
    Berumen L; Franco Guevara G
    Rev Med Hosp Gen (Mex); 1965 Mar; 28(3):175-82. PubMed ID: 5318927
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of radiologic and cytostatic combination therapy in malignant diseases].
    Hammer B
    Wien Med Wochenschr; 1967 Jun; 117(25):637-41. PubMed ID: 5585442
    [No Abstract]   [Full Text] [Related]  

  • 19. New chemotherapeutic agents in Hodgkin's disease.
    Hall TC
    Cancer Res; 1966 Jun; 26(6):1297-302. PubMed ID: 5947354
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytostatic therapy of malignant lymphoma].
    Kühböck J
    Wien Klin Wochenschr; 1971 Jul; 83(27):516-22. PubMed ID: 5123478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.